AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36167599 — intervention group
Group type: COMPARATOR
Intervention: Degarelix + Matching Placebo for 3 months
Number of subjects: 89
Study 36167599 — intervention group
Group type: EXPERIMENTAL
Intervention: Degarelix + Apalutamide
Number of subjects: 89
Study 33958669 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracorporeal anastomosis (IA)
Number of subjects: 59
Study 33958669 — intervention group
Group type: COMPARATOR
Intervention: Extracorporeal anastomosis (EA)
Number of subjects: 59
Study 36402355 — intervention group
Group type: EXPERIMENTAL
Intervention: Tight control (140/90 mmHg)
Number of subjects: 256
Study 36402355 — intervention group
Group type: COMPARATOR
Intervention: Liberal control (150/95 mmHg)
Number of subjects: 256
Study 32091602 — intervention group
Group type: EXPERIMENTAL
Intervention: SAM Extremity Tourniquet (SAM-XT)
Number of subjects: 60
Study 32091602 — intervention group
Group type: EXPERIMENTAL
Intervention: CAT Generation 7 (CAT7)
Number of subjects: 60
Study 32091602 — intervention group
Group type: COMPARATOR
Intervention: SOF Tactical Tourniquet Wide (SOFTT-W)
Number of subjects: 60
Study 32091602 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of slack between CAT7 and SAM-XT
Number of subjects: 60
Study 32091602 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between slack and hemorrhage control rate
Number of subjects: 60
Study 33729046 — intervention group
Group type: EXPERIMENTAL
Intervention: High bullying victimization and perpetration class (fifth graders)
Number of subjects: 4058
Study 33729046 — intervention group
Group type: EXPERIMENTAL
Intervention: High bullying victimization class (fifth graders)
Number of subjects: 4058
Study 33729046 — intervention group
Group type: EXPERIMENTAL
Intervention: Seventh-grade students
Number of subjects: 4058
Study 33764567 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolutegravir (DTG)
Number of subjects: 39
Study 35644332 — intervention group
Group type: EXPERIMENTAL
Intervention: Alirocumab
Number of subjects: 18924
Study 35644332 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18924
Study 33764461 — intervention group
Group type: EXPERIMENTAL
Intervention: TEXT4myBACK intervention (4 semi-personalized text messages per week for 12 weeks)
Number of subjects: 304
Study 33764461 — intervention group
Group type: COMPARATOR
Intervention: Control group (1 text message with a link to LBP and diet online information package)
Number of subjects: 304
Study 33764461 — intervention group
Group type: EXPERIMENTAL
Intervention: TEXT4myBACK intervention
Number of subjects: 304
Study 33764461 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 304
Study 33220737 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygenated hypothermic machine perfusion (HMPO2)
Number of subjects: 197
Study 33220737 — intervention group
Group type: COMPARATOR
Intervention: HMP without oxygenation (HMP)
Number of subjects: 197
Study 33200382 — intervention group
Group type: EXPERIMENTAL
Intervention: Extrinsic message (Easy Extrinsic, Hard Extrinsic)
Number of subjects: 308
Study 33200382 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training workout with motivational message
Number of subjects: 308
Study 36086748 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan-statin group (n=48)
Number of subjects: 99
Study 36086748 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine-statin group (n=51)
Number of subjects: 99
Study 33938653 — intervention group
Group type: EXPERIMENTAL
Intervention: anterior QLB (n=25) with preoperative ropivacaine 3.75 mg/mL, 20 mL bilaterally
Number of subjects: 70
Study 33938653 — intervention group
Group type: COMPARATOR
Intervention: placebo QLB (n=22) with preoperative isotonic saline, 20 mL bilaterally
Number of subjects: 70
Study 33938653 — intervention group
Group type: COMPARATOR
Intervention: controls (n=23) given only standard intravenous and oral analgesia
Number of subjects: 70
Study 616774593 — intervention group
Group type: EXPERIMENTAL
Intervention: PDCA cycle based nursing care
Number of subjects: 86
Study 616774593 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing care
Number of subjects: 86
Study 34895364 — intervention group
Group type: EXPERIMENTAL
Intervention: Lacrimal and double nasal mucosal flaps
Number of subjects: 90
Study 34895364 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic dacryocystorhinostomy without flap preservation
Number of subjects: 90
Study 32222762 — intervention group
Group type: EXPERIMENTAL
Intervention: HTF culture medium
Number of subjects: 97
Study 32222762 — intervention group
Group type: COMPARATOR
Intervention: G5 culture medium
Number of subjects: 97
Study 32222762 — intervention group
Group type: EXPERIMENTAL
Intervention: IVF placenta
Number of subjects: 97
Study 32222762 — intervention group
Group type: EXPERIMENTAL
Intervention: G5 placenta
Number of subjects: 97
Study 32222762 — intervention group
Group type: EXPERIMENTAL
Intervention: HTF placenta
Number of subjects: 97
Study 35704475 — intervention group
Group type: EXPERIMENTAL
Intervention: ASC-enriched fat grafting (10 × 10^6 ASCs/mL fat graft)
Number of subjects: 10
Study 35704475 — intervention group
Group type: COMPARATOR
Intervention: Placebo-enriched fat grafting
Number of subjects: 10
Study 32690103 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning auto-segmentation (DLAS)
Number of subjects: 56
Study 32690103 — intervention group
Group type: COMPARATOR
Intervention: Atlas-based auto-segmentation (ABAS)
Number of subjects: 56
Study 33408315 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg rosuvastatin once daily
Number of subjects: 120
Study 33408315 — intervention group
Group type: COMPARATOR
Intervention: 2.5 mg rosuvastatin once daily
Number of subjects: 120
Study 33715955 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular coffee (80 mL)
Number of subjects: 156
Study 33715955 — intervention group
Group type: COMPARATOR
Intervention: Decaffeinated coffee (80 mL, placebo)
Number of subjects: 156
Study 32787879 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3PUFA supplementation (3.3 g/day)
Number of subjects: 27
Study 32787879 — intervention group
Group type: COMPARATOR
Intervention: Corn oil placebo (PLA) (3.0 g/day)
Number of subjects: 27
Study 35485000 — intervention group
Group type: EXPERIMENTAL
Intervention: VR helmets
Number of subjects: 128
Study 35485000 — intervention group
Group type: COMPARATOR
Intervention: Control (traditional behavior guidance procedures)
Number of subjects: 128
Study 33849118 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchoalveolar lavage under fiberoptic bronchoscopy
Number of subjects: 148
Study 33849118 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 148
Study 34355611 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine (LDX)
Number of subjects: 20
Study 34355611 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 20
Study 32424499 — intervention group
Group type: EXPERIMENTAL
Intervention: Brace and physiotherapy group (Group 2)
Number of subjects: 30
Study 32424499 — intervention group
Group type: COMPARATOR
Intervention: Brace treatment only group (Group 1)
Number of subjects: 30
Study 615918091 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide (ACZ) plus diet
Number of subjects: 126
Study 615918091 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus diet
Number of subjects: 126
Study 36166771 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine 20 mg daily for 90 days
Number of subjects: 17
Study 36166771 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 33159533 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based impact exercise intervention (16 weeks, progressively increasing to 50 multi-directional unilateral hops on each leg daily)
Number of subjects: 50
Study 33159533 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based impact exercise intervention
Number of subjects: 50
Study 36201325 — intervention group
Group type: EXPERIMENTAL
Intervention: GAL (0.4 g.min‐1)
Number of subjects: 14
Study 36201325 — intervention group
Group type: EXPERIMENTAL
Intervention: GAL+GLU (0.4 g.min‐1 galactose and 0.8 g.min‐1 glucose)
Number of subjects: 14
Study 36201325 — intervention group
Group type: EXPERIMENTAL
Intervention: COMBINE (GAL*+GLU*)
Number of subjects: 14
Study 36201325 — intervention group
Group type: COMPARATOR
Intervention: GLU (0.8 g.min‐1)
Number of subjects: 14
Study 33956804 — intervention group
Group type: EXPERIMENTAL
Intervention: SP16 (0.2 mg/kg)
Number of subjects: 0
Study 33956804 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33956804 — intervention group
Group type: EXPERIMENTAL
Intervention: SP16 (0.0125 mg/kg and 0.05 mg/kg)
Number of subjects: 0
Study 33956804 — intervention group
Group type: EXPERIMENTAL
Intervention: SP16
Number of subjects: 0
Study 32324672 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal Bupivacaine (LB)
Number of subjects: 195
Study 33468340 — intervention group
Group type: EXPERIMENTAL
Intervention: Air cell-based pad
Number of subjects: 27
Study 33468340 — intervention group
Group type: COMPARATOR
Intervention: Gel pad
Number of subjects: 27
Study 35277845 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-freezing PBM exposure (810 nm, diode laser, and 0.6 J/cm2)
Number of subjects: 24
Study 35277845 — intervention group
Group type: COMPARATOR
Intervention: Conventional sperm cryopreservation
Number of subjects: 24
Study 35277845 — intervention group
Group type: EXPERIMENTAL
Intervention: Post freezing and thawing PBM exposure
Number of subjects: 24
Study 33317612 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive radical trachelectomy (MIRT)
Number of subjects: 414
Study 33317612 — intervention group
Group type: COMPARATOR
Intervention: Abdominal radical trachelectomy (ART)
Number of subjects: 414
Study 35507955 — intervention group
Group type: EXPERIMENTAL
Intervention: Momordica charantia (MC) 2000 mg/day for 12 weeks
Number of subjects: 24
Study 35507955 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 34893092 — intervention group
Group type: EXPERIMENTAL
Intervention: Prefabricated contoured foot orthoses
Number of subjects: 36
Study 34893092 — intervention group
Group type: COMPARATOR
Intervention: Flat shoe insoles
Number of subjects: 36
Study 33920725 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium yeast (200 µg/day) and coenzyme Q10 (200 mg/day)
Number of subjects: 213
Study 33920725 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 213
Study 32508211 — intervention group
Group type: EXPERIMENTAL
Intervention: Attribution-retraining
Number of subjects: 565
Study 32508211 — intervention group
Group type: COMPARATOR
Intervention: Health education (Control)
Number of subjects: 565
Study 32377302 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma selenium concentrations in MetS group (93.88 μg/L)
Number of subjects: 1279
Study 32377302 — intervention group
Group type: COMPARATOR
Intervention: Quartile 1 (<82.36 μg/L)
Number of subjects: 1279
Study 32377302 — intervention group
Group type: COMPARATOR
Intervention: Quartile 2 (82.37-92.66 μg/L)
Number of subjects: 1279
Study 32377302 — intervention group
Group type: COMPARATOR
Intervention: Quartile 3 (92.67-103.52 μg/L)
Number of subjects: 1279
Study 32377302 — intervention group
Group type: EXPERIMENTAL
Intervention: Cubic spline analysis of plasma selenium
Number of subjects: 1279
Study 32377302 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma selenium
Number of subjects: 1279
Study 32377302 — intervention group
Group type: COMPARATOR
Intervention: GA and GA+AA genotype carriers
Number of subjects: 1279
Study 36451466 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) for 12 weeks
Number of subjects: 76
Study 36451466 — intervention group
Group type: COMPARATOR
Intervention: Waitlist Control
Number of subjects: 76
Study 32647353 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant SBRT delivered in three fractions of 8 Gy over 5 days completed 2 weeks before surgery
Number of subjects: 16
Study 32647353 — intervention group
Group type: COMPARATOR
Intervention: No neoadjuvant SBRT
Number of subjects: 16
Study 32588788 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemospray therapy
Number of subjects: 73
Study 34348648 — intervention group
Group type: EXPERIMENTAL
Intervention: LightGBM model
Number of subjects: 1796
Study 33075037 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision rule-guided antibiotic prescription (n = 402)
Number of subjects: 999
Study 33075037 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n = 597)
Number of subjects: 999
Study 33075037 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost-of-illness for children under 5 years with suspected lower RTIs
Number of subjects: 999
Study 32273250 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D printed model of Henle trunk plus surgical video (3D‐printing group)
Number of subjects: 47
Study 32273250 — intervention group
Group type: COMPARATOR
Intervention: 2D image of Henle trunk plus surgical video (2D image group)
Number of subjects: 47
Study 32273250 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D printed model of Henle trunk
Number of subjects: 47
Study 32273250 — intervention group
Group type: COMPARATOR
Intervention: 2D image group
Number of subjects: 47
Study 34952302 — intervention group
Group type: EXPERIMENTAL
Intervention: Synchronous classes (n=60)
Number of subjects: 127
Study 34952302 — intervention group
Group type: COMPARATOR
Intervention: Asynchronous classes (n=67)
Number of subjects: 127
Study 32586433 — intervention group
Group type: EXPERIMENTAL
Intervention: Shamiri group intervention (4-week intervention including growth mindset, gratitude, and value affirmation exercises)
Number of subjects: 51
Study 32586433 — intervention group
Group type: COMPARATOR
Intervention: Study skills control intervention (4-week control intervention)
Number of subjects: 51
Study 35500012 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion regulation instructions (distancing from an emotionally evocative film clip)
Number of subjects: 168
Study 35500012 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion regulation instructions (immersing in the film clip)
Number of subjects: 168
Study 35500012 — intervention group
Group type: EXPERIMENTAL
Intervention: Viewing affirming film clip
Number of subjects: 168
Study 35500012 — intervention group
Group type: COMPARATOR
Intervention: Viewing minority stress film clip
Number of subjects: 168
Study 33084081 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (20 mg)
Number of subjects: 30
Study 33084081 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 30
Study 34398961 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to health news stories and social media posts featuring conflict at Times 1 and 2
Number of subjects: 2716
Study 34398961 — intervention group
Group type: COMPARATOR
Intervention: Exposure to health news stories and social media posts that did not feature conflict at Times 1 and 2
Number of subjects: 2716
Study 35502891 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Divas intervention (6 peer-led individual sessions and one group workshop)
Number of subjects: 278
Study 35502891 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 278
Study 32196636 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured physical activity (PA) intervention including two center-based plus three to four home-based exercise sessions per week, aiming for 150 minutes of walking weekly for 2.5 years on average
Number of subjects: 507
Study 32196636 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured physical activity (PA) intervention
Number of subjects: 507
Study 33501845 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive Cogmed Working Memory Training
Number of subjects: 0
Study 33501845 — intervention group
Group type: COMPARATOR
Intervention: Nonadaptive (control) Cogmed Working Memory Training
Number of subjects: 0
Study 33501845 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Cogmed groups (Adaptive and Nonadaptive)
Number of subjects: 0
Study 33501845 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-reported measures
Number of subjects: 0
Study 33298305 — intervention group
Group type: EXPERIMENTAL
Intervention: e‐SBIRT
Number of subjects: 439
Study 33298305 — intervention group
Group type: EXPERIMENTAL
Intervention: SBIRT
Number of subjects: 439
Study 33298305 — intervention group
Group type: COMPARATOR
Intervention: EUC
Number of subjects: 439
Study 34375444 — intervention group
Group type: EXPERIMENTAL
Intervention: ACT-based intervention
Number of subjects: 94
Study 34375444 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 94
Study 34694346 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 15 mg once daily
Number of subjects: 7107
Study 34694346 — intervention group
Group type: COMPARATOR
Intervention: Aspirin 100 mg once daily
Number of subjects: 7107
Study 33316278 — intervention group
Group type: EXPERIMENTAL
Intervention: Navigator group
Number of subjects: 932
Study 33316278 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonwhite race
Number of subjects: 932
Study 33183320 — intervention group
Group type: EXPERIMENTAL
Intervention: BUDCA (berberine ursodeoxycholate) at a dose of 2000 mg per day for 28 days
Number of subjects: 50
Study 33183320 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 35428650 — intervention group
Group type: EXPERIMENTAL
Intervention: Treg therapy (TR001)
Number of subjects: 60
Study 35428650 — intervention group
Group type: COMPARATOR
Intervention: Standard clinical care (control)
Number of subjects: 60
Study 34303447 — intervention group
Group type: EXPERIMENTAL
Intervention: Challenging Horizons Program (CHP)
Number of subjects: 186
Study 34303447 — intervention group
Group type: COMPARATOR
Intervention: Community Care (CC)
Number of subjects: 186
Study 33754516 — intervention group
Group type: EXPERIMENTAL
Intervention: 4mg submucosal dexamethasone
Number of subjects: 150
Study 33754516 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 35867209 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk-score model incorporating factors such as age, sex, immune compromise, presence of microsatellites, and regional nodal involvement.
Number of subjects: 604
Study 35867209 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk-score model with ≤ 4.00 points
Number of subjects: 604
Study 35867209 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk-score model with > 4.00 points
Number of subjects: 604
Study 35867209 — intervention group
Group type: EXPERIMENTAL
Intervention: Pathologic stage I/II patients with > 4.00 points (n = 49)
Number of subjects: 604
Study 35867209 — intervention group
Group type: EXPERIMENTAL
Intervention: Pathologic stage III patients with ≤ 4.00 points (n = 62)
Number of subjects: 604
Study 32778017 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine, Methotrexate, and Mycophenolate Mofetil
Number of subjects: 134
Study 32778017 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine and Methotrexate
Number of subjects: 134
Study 33998561 — intervention group
Group type: EXPERIMENTAL
Intervention: Purposeful activity-based electrical stimulation therapy (PA‐EST) for 3 months (phase 1)
Number of subjects: 8
Study 33998561 — intervention group
Group type: COMPARATOR
Intervention: Standard stretching and exercise for 3 months (phase 2)
Number of subjects: 8
Study 33215554 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-Delivered Cognitive Behavioral Therapy (Living with Deadly Thoughts)
Number of subjects: 418
Study 33215554 — intervention group
Group type: COMPARATOR
Intervention: Attention Control Condition
Number of subjects: 418
Study 33306414 — intervention group
Group type: EXPERIMENTAL
Intervention: RRx-001 (4 mg once weekly until progression)
Number of subjects: 14
Study 33306414 — intervention group
Group type: EXPERIMENTAL
Intervention: Etoposide platinum (EP) chemotherapy (etoposide 100 mg/m2 IV on days 1-3, cisplatin 80 mg/m2 IV on day 1 or carboplatin AUC 5-6 IV on day 1)
Number of subjects: 14
Study 32795267 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-based learning (n = 79)
Number of subjects: 157
Study 32795267 — intervention group
Group type: COMPARATOR
Intervention: Home-sent patient information (controls; n = 78)
Number of subjects: 157
Study 34999207 — intervention group
Group type: EXPERIMENTAL
Intervention: Vascepa 2 g twice daily
Number of subjects: 66
Study 34999207 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate 145 mg daily
Number of subjects: 66
Study 34999207 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate in patients with baseline triglycerides <250 mg/dL
Number of subjects: 66
Study 34999207 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate in patients with baseline triglycerides ≥250 mg/dL
Number of subjects: 66
Study 32945207 — intervention group
Group type: EXPERIMENTAL
Intervention: Type B lenses
Number of subjects: 80
Study 32945207 — intervention group
Group type: COMPARATOR
Intervention: X50
Number of subjects: 80
Study 32996444 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic administration
Number of subjects: 155
Study 32996444 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in gut microbial diversity
Number of subjects: 155
Study 35751891 — intervention group
Group type: EXPERIMENTAL
Intervention: Kundur (Boswellia serrata) 1g vaginal insert daily for 21 days
Number of subjects: 40
Study 35751891 — intervention group
Group type: COMPARATOR
Intervention: Miconazole (2% w/w) 100mg vaginal suppository daily for 7 days
Number of subjects: 40
Study 34491649 — intervention group
Group type: EXPERIMENTAL
Intervention: Bo's abdominal acupuncture (combined with methotrexate treatment)
Number of subjects: 104
Study 34491649 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate tablets (5 mg once a week)
Number of subjects: 104
Study 32971304 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Pavlovian co-conditioning mechanism
Number of subjects: 0
Study 35564645 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevate Self Growth program
Number of subjects: 19
Study 34300205 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine-remifentanil (DR group)
Number of subjects: 62
Study 34300205 — intervention group
Group type: COMPARATOR
Intervention: Propofol-remifentanil (PR group)
Number of subjects: 62
Study 34552035 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric trunk strength (ITS) testing for trunk flexors, extensors, and lateral flexors
Number of subjects: 567
Study 33165312 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher levels of attrition
Number of subjects: 7